The Society of Cosmetic Scientists promotes education, research and collaboration to advance the science of cosmetics

Share this:

Events Archive

Back to archive >>




Programme can be found here


(Presentations open to Members and Non-Members)


Prof Alan Smeaton, Insight Centre for Data Analytics, Dublin City University - keynote speaker

Alan Smeaton is Professor of Computing at Dublin City University where he is Founding Director of the Insight Centre for Data Analytics. His research expertise is in data analysis, especially as it is applied to image, video, and various forms of personal data. 

Synopsis: Sleep … ZZZzzz...

In this presentation I will review the importance and the impact of regular and quality sleep on our health, our wellness and our performance in everyday tasks. I will outline some of the consumer-level techniques now available to allow us to measure and regularly monitor our own sleep in non-laboratory settings, and what we can learn from these. I will also address some of the mis-conceptions many of us have about our sleep, the good and the many bad habits we tend to have around this most important activity in our lives


Prof Christine Loscher, Associate Dean for Research, FSH, School of Biotechnology, Dublin City University

Professor Christine Loscher completed her PhD in Immunology at NUI, Maynooth in 2000 and was awarded a Health Research Board Fellowship to pursue her postdoctoral studies at Trinity College Dublin. In 2003 she moved to the Institute of Molecular Medicine at St James Hospital to continue her research and then was appointed to a permanent academic position at DCU in 2005. She leads the Immunomodulation Research Group at DCU which has a focus on translating how modulation of the immune response has health benefits. Her focus includes discovering new anti-inflammatory compounds and ingredients that can be used in the pharma and food industry. She is a Principal Investigator in the Food for Health Ireland Technology Centre and served on the Scientific Advisory Council at Kerry Foods from 2015 to 2017. She has developed significant expertise in commercial research and industry engagement and has secured over €5M in external funding for her research.  She also designed and implemented the BioAT Programme, a €5.6M multi-disciplinary graduate education/training and research programme spanning 6 academic institutions.  She has recently led a €16M project to build a Nano-Bioanalytical Research Facility at DCU which is used now by more than 30 research groups across the University.  In 2014 she was named in Silicon Republics top 100 Women in STEM and in 2015 she was a speaker at InspireFest. In 2016 she delivered a TEDx talk to communicate her views on the Future of Food and in 2018 she was included in Silicon Republic’s  “22 high-flying scientists making the world a better place in 2019”. She is currently the Associate Dean for Research in the Faculty of Science & Health at DCU.    

Synopsis: Discovering new ways to treat inflammation as we age

Inflammation is now known to be a key driver of a wide range of chronic diseases such as diabetes, cardiovascular disease and cancer. Lifestyle choices including our food and our physical behaviours can greatly influence the level of inflammation in our body but so too does the process of ageing. My research aims to discover new compounds that can be used to suppress inflammation and in this lecture I will discuss a novel compound that we have recently discovered from a marine source that can treat skin inflammation. 


Dr Ronan Murphy Department of Health & human Performance, Dublin City University 

Biog: University of Newcastle-Upon-Tyne, UK (2010) Advanced Flow Cytometry. Max Plank Institute for Cell & Molecular Biology, Dresden, Germany (2004) Advanced Imaging. Dublin Institute of Technology (1997-1998) Dip IT. N.U.I. Galway: Cell and Molecular Biology Group, PhD Molecular Genetics of Hereditary Colorectal Cancer. N.U.I. Galway BSc (Hons) Biochemistry. London College of Music (1985-1989) A.L.C.M.

Synopsis: Development of Integrated Cell & Molecular Physiological Platforms to Investigate the Efficacy of Natural Products on Health; In Vivo, In Vitro and Organotypic Model Approaches.

It has been asserted that clinical trials hold the answer to questions about the beneficial effects of bio-functional natural products on human health, including that of skin. This is not a simple case and in fact is quiet complex. Clinical trials give us rigorous answers to restricted questions and were developed for therapeutic situations to determine which treatment was better for curing a specific disease. Rarely can more than one or two substances be tested, usually at a single dose. Subjects have to be persons with pre-existing conditions or an extremely high risk of the disease in question. Most important, clinical trials test the efficacy of an agent that is administered for a limited time, beginning fairly late in life. Few trials will tell us anything about whether natural products (dietary and/or topical) might contribute to prevention of long-term chronic conditions, including InflammAging. However, the questions about primary and secondary prevention that are of interest may involve persons with no unusual risk of disease, lifetimes of exposure, enormously complex interactions among nutrients, and the effects of these nutrients on hundreds of often uncommon disease conditions. Classical Clinical trials simply cannot answer these questions. We have endeavored to develop integrated technological platforms to overcome such limitations. These involve using an holistic approach, encompassing molecular response, cellular function and a well-controlled biomarker approach that takes into account environmental and genetic architecture.

The frequent failure of high-throughput screening cell-based tools to accurately predict in vivo responses, coupled with limitations of animal models in predicting human safety or drug efficacy, impairs the de-risking process for biotechnology/pharmaceutical companies as they make important decisions to enter human clinical trials. We have developed ‘organotypic systems’, based on advanced technological platforms to address this gap in expertise and service currently in the market, while addressing this deficit between these screening and in vivo studies. Decisions from translational systems that bridge basic bio-functional efficacy and toxicity with clinical outcome must be benchmarked against human-relevant endpoints and clinical data for early meaningful pre-clinical decisions. The use of dynamic human primary cell systems coupled with emerging molecular and genetic technologies that allow precise control of the culture environment and analysis of meaningful endpoints paves the way for human organotypic systems as a major initiative in de-risking the novel compound discovery and development process. This will facilitate the development of new potent nutraceuticals and cosmeceuticals, thus optimizing lifestyle strategies to increase an ageing well paradigm and slowing biological epigenetic drift.


Dr Aoife Morrin, Department of Chemical Sciences, Dublin City University 

Aoife Morrin is Associate Professor at the School of Chemical Sciences and Funded Investigator at INSIGHT Centre for Data Analytics (Dublin City University). Her research focus has been on soft responsive materials and new approaches to using these in chemical and biochemical analysis. She is currently funded by Science Foundation Ireland for a research programme related to wearable sensing platforms that can harvest biochemical information from the body.

Synopsis: Wearable platforms for monitoring skin physiology for health and wellness applications

Wearable sensing technologies have emerged over the last decade and range from those that record physical activity levels to tracking physiological processes such as cardiac rhythm, blood pressure  etc, and most recently to the biochemical analysis of the skin itself, often via the extraction and analysis of skin-derived biofluids such as sweat. This talk will introduce wearable sensing platforms capable of such biochemical analysis where the range and types of biochemical information that can be obtained will be discussed, along with the state of the art in terms of the wearable approaches that are being exploited today by the health and beauty industry. The focus of the presentation will be around the present and future opportunities that these platforms present for the beauty industry. 


Time AGM 3pm followed by presentations 

Venue Smock Alley Theatre 1662, Dublin, Ireland


Copyright © 2020 Society of Cosmetic Scientists. All rights reserved.